Editorial
A major milestone for Translational Cancer Research: indexing in PubMed/PubMed Central
Translational Cancer Research
2022;
11
(1)
:1-2
.
(26 January 2022)
Original Article
Tumor-endogenous PD-1 promotes cell proliferation and predicts poor survival in non-small cell lung cancer
Translational Cancer Research
2022;
11
(1)
:3-13
.
(26 January 2022)
A novel signature based on autophagy-related lncRNA for prognostic prediction and candidate drugs for lung adenocarcinoma
Translational Cancer Research
2022;
11
(1)
:14-28
.
(26 January 2022)
Prognostic implications of combined high expression of CD47 and MCT1 in breast cancer: a retrospective study during a 10-year period
Translational Cancer Research
2022;
11
(1)
:29-42
.
(26 January 2022)
Pure laparoscopic liver resection versus percutaneous radiofrequency ablation for small hepatocellular carcinoma: a propensity score and multivariate analysis
Translational Cancer Research
2022;
11
(1)
:43-51
.
(26 January 2022)
Establishment and validation of a novel nomogram for survival prediction of ovarian carcinosarcoma
Translational Cancer Research
2022;
11
(1)
:52-62
.
(26 January 2022)
Preoperative blood testing for glioblastoma, brain metastases, and primary central nervous system lymphoma differentiation
Translational Cancer Research
2022;
11
(1)
:63-71
.
(26 January 2022)
Uniportal video-assisted thoracoscopic surgery (VATS) for the treatment of early-stage lung cancer with whole pleural adhesion
Translational Cancer Research
2022;
11
(1)
:72-84
.
(26 January 2022)
Knockdown of EphB3 inhibits cell proliferation partly through the AKT signaling pathway and represses epithelial-mesenchymal transition in esophageal squamous cell carcinoma
Translational Cancer Research
2022;
11
(1)
:85-98
.
(26 January 2022)
A meta-analysis comparing hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma
Translational Cancer Research
2022;
11
(1)
:99-112
.
(26 January 2022)
Bone metastasis of esophageal carcinoma diagnosed as a first primary tumor: a population-based study
Translational Cancer Research
2022;
11
(1)
:113-123
.
(26 January 2022)
Association between family history and prognosis of patients with colorectal cancer: a systematic review and meta-analysis
Translational Cancer Research
2022;
11
(1)
:124-133
.
(26 January 2022)
Patient-derived tumor spheroid cultures as a promising tool to assist personalized therapeutic decisions in breast cancer
Translational Cancer Research
2022;
11
(1)
:134-147
.
(26 January 2022)
The trends and efficacy of operation in the treatment of hepatocellular carcinoma
Translational Cancer Research
2022;
11
(1)
:148-159
.
(26 January 2022)
Predictive role of the monocyte-to-lymphocyte ratio in advanced hepatocellular carcinoma patients receiving anti-PD-1 therapy
Translational Cancer Research
2022;
11
(1)
:160-170
.
(26 January 2022)
Survival outcomes in unresectable metastatic rectal cancer patients after both primary site resection and chemoradiotherapy: a SEER-based observational study
Translational Cancer Research
2022;
11
(1)
:171-180
.
(26 January 2022)
A novel immune checkpoint-related gene signature for predicting overall survival and immune status in triple-negative breast cancer
Translational Cancer Research
2022;
11
(1)
:181-192
.
(26 January 2022)
Assessment of POLE and POLD1 mutations as prognosis and immunotherapy biomarkers for stomach adenocarcinoma
Translational Cancer Research
2022;
11
(1)
:193-205
.
(26 January 2022)
Carfilzomib inhibits the proliferation and apoptosis of multiple myeloma cells by inhibiting STAT1/COX-2/iNOS signaling pathway
Translational Cancer Research
2022;
11
(1)
:206-216
.
(26 January 2022)
The correlation between common postoperative complications and quality of life, serum tumor markers, and prognosis in patients with esophageal cancer
Translational Cancer Research
2022;
11
(1)
:217-226
.
(26 January 2022)
Identification of potential key molecular biomarkers in lung adenocarcinoma by bioinformatics analysis
Translational Cancer Research
2022;
11
(1)
:227-241
.
(26 January 2022)
Circular RNA circTADA2A promotes the proliferation, invasion, and migration of non-small cell lung cancer cells via the miR-450b-3p/HMGN5 signaling pathway
Translational Cancer Research
2022;
11
(1)
:242-251
.
(26 January 2022)
Safety and efficacy of sintilimab combination therapy for the treatment of 48 patients with advanced malignant tumors
Translational Cancer Research
2022;
11
(1)
:252-261
.
(26 January 2022)
Review Article
A narrative review for the Hippo-YAP pathway in cancer survival and immunity: the Yin-Yang dynamics
Translational Cancer Research
2022;
11
(1)
:262-275
.
(26 January 2022)
Efficacy and safety of regorafenib and fruquintinib as third-line treatment for colorectal cancer: a narrative review
Translational Cancer Research
2022;
11
(1)
:276-287
.
(26 January 2022)
Case Report
Clear cell sarcoma of the kidney in an adult: a case report and literature review
Translational Cancer Research
2022;
11
(1)
:288-294
.
(26 January 2022)
Effectiveness of afatinib in an NSCLC patient with EGFR mutation and early progression to osimertinib: a case report
Translational Cancer Research
2022;
11
(1)
:295-298
.
(26 January 2022)
Metastatic papillary thyroid carcinoma with no primary tumor in the thyroid gland: a case report and review of literature
Translational Cancer Research
2022;
11
(1)
:299-305
.
(26 January 2022)
